Clinical Program Leader / Clinical Program Leaderess
Novartis Pharma AG - June 20, 2025
Job ID
REQ-10051970
Job Posting Date
May 21, 2025
Location
Switzerland
Summary
This role involves providing strategic medical guidance and leading the development of experimental oncology agents within the TCO portfolio, transitioning from preclinical development through clinical First in Human and Phase 1b/2 studies. As a Clinical Program Leader, you will have the crucial responsibility of coordinating the planning, execution, and interpretation of early-phase oncology clinical trials.
About the Role
With over 6,000 associates in the BioMedical Research (BR) division, Novartis serves as the innovation engine focused on harnessing powerful new technologies that have the potential to enable therapeutic breakthroughs for patients. Within Translational Clinical Oncology, our global team of disease, modality, and trial experts is dedicated to delivering innovative therapies through an in-depth understanding of cancer biology, pioneering study design, agile evidence-based decision-making, and collaboration with the scientific and medical community to expedite new medicines for patients.
Your Responsibilities
Your responsibilities will include, but are not limited to:
Acting as a clinical leader for assigned global clinical program(s), driving medical strategy implementation and operational deliverables for investigational products in a defined therapeutic area.
Ensuring effective cross-functional communications to align with global strategy and leading the development of clinical sections of trial and program-level regulatory documents.
Serving as the medical expert, engaging with external stakeholders (e.g., regulatory authorities, key opinion leaders, data monitoring committees, advisory boards) and internal Novartis stakeholders.
Contributing to the medical/scientific training of relevant Novartis stakeholders and may serve as a speaker for such training.
Leading global initiatives (e.g., process improvement, training, SOP development) within the Clinical Development function.
Bringing experience from leading early or late-phase oncology clinical programs in the pharma/biotech industry, complemented by credible experience from an academic medical center.
Demonstrating a track record of significant contributions to the field over time, with a focus on creating new concepts and exploring new clinical discovery opportunities.
Role Requirements
What you'll bring to the role:
A medical degree; oncology board certification is preferred, alongside a PhD level in basic sciences or equivalent expertise.
Clinical Development experience within the pharma/biotech industry in Oncology is essential.
A minimum of 3 years of technical, operational, and managerial experience in planning, executing, reporting, and designing clinical trial studies in a pharmaceutical or biotech company.
Strong knowledge of Good Clinical Practice, clinical trial design, statistics, regulatory processes, and global clinical development processes.
Familiarity with oncology and experience in early clinical development is preferred.
Excellent communication, writing, and organizational skills; fluent in English (both written and spoken).
Why Novartis?
Our purpose is to reimagine medicine to improve and extend people's lives, and our vision is to become the most valued and trusted medicines company globally. This mission is driven by our dedicated associates who work tirelessly to achieve our ambitions. Join us in this endeavor!
Commitment to Diversity and Inclusion
Novartis is committed to building an outstanding, inclusive work environment with diverse teams that represent the patients and communities we serve.
Accessibility & Accommodation
We at Novartis are dedicated to providing reasonable accommodations to all individuals. If you require accommodations due to a medical condition or disability, please contact us at Show e-mailm"> to discuss your needs.
Application Process
Apply online using the form below. Please note that only applications matching the job profile will be considered.